Prokidney (PROK) Assets Average (2021 - 2026)
Prokidney (PROK) posted quarterly Assets Average of $314.2 million for Q1 2026, down 25.83% year-over-year from $423.6 million in Q1 2025, and down 8.56% quarter-over-quarter from $343.6 million in Q4 2025.
Prokidney (PROK) Assets Average (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Assets Average for 6 consecutive years, with $314.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 25.83% year-over-year to $314.2 million; the TTM figure through Mar 2026 stood at $314.2 million (down 25.83% YoY), while the FY2025 annual figure was $388.3 million, down 9.86% from the prior year.
- Assets Average fell to $314.2 million in Q1 2026 per PROK's latest filing, from $343.6 million in the prior quarter.
- Across five years, Assets Average topped out at $525.2 million in Q4 2022 and bottomed at $145.5 million in Q1 2022.
- Historically, Assets Average has averaged $402.3 million across 5 years, with a median of $423.6 million in 2025.
- Annual changes were most pronounced in 2022 — Assets Average jumped 260.06% — and 2026, when it slipped 25.83%.
- Prokidney's Assets Average stood at $525.2 million in 2022, then dropped by 16.95% to $436.2 million in 2023, then gained by 4.99% to $457.9 million in 2024, then decreased by 24.97% to $343.6 million in 2025, then decreased by 8.56% to $314.2 million in 2026.
- Business Quant data shows PROK's Assets Average at $314.2 million in Q1 2026, $343.6 million in Q4 2025, and $361.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Prokidney | 679.95 Mn | 679.95 Mn | - | 270.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 270.90 Mn |
| Mar 31, 2026 | 314.18 Mn |
| Dec 31, 2025 | 343.59 Mn |
| Sep 30, 2025 | 361.87 Mn |
| Jun 30, 2025 | 389.10 Mn |
| Mar 31, 2025 | 423.57 Mn |
| Dec 31, 2024 | 457.93 Mn |
| Sep 30, 2024 | 486.98 Mn |
| Jun 30, 2024 | 443.46 Mn |
| Mar 31, 2024 | 404.16 Mn |
| Dec 31, 2023 | 436.18 Mn |
| Sep 30, 2023 | 468.01 Mn |
| Jun 30, 2023 | 489.69 Mn |
| Mar 31, 2023 | 506.57 Mn |
| Dec 31, 2022 | 525.22 Mn |
| Sep 30, 2022 | 391.72 Mn |
| Jun 30, 2022 | 250.88 Mn |
| Mar 31, 2022 | 145.53 Mn |
| Dec 31, 2021 | 145.87 Mn |
| Sep 30, 2021 | 126.03 Mn |